Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)
SEK 1.48
(0.68%)
SEK 1.48
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.22 Million | -19.63 Million | -19.18 Million | -8.49 Million | -11.22 Million | -4.57 Million |
| Net Income | -21.09 Million | -20.91 Million | -17.07 Million | -10.82 Million | -11.97 Million | -4.79 Million |
| Depreciation & Amortization | 2.68 Million | 2.94 Million | 2.81 Million | 1.92 Million | 1.82 Million | 1.15 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 450 Thousand | -101 Thousand | -4.23 Million | 1.54 Million | -711 Thousand | -934 Thousand |
| Other non-cash items | 5.54 Million | -1.56 Million | -686 Thousand | -1.14 Million | -369 Thousand | 5.49 Million |
| Investing Cash Flow | -467 Thousand | -603 Thousand | -3.33 Million | -1.82 Million | -4.31 Million | -8.14 Million |
| Investments in PPE | -680 Thousand | -331 Thousand | -3.18 Million | -1.82 Million | -4.31 Million | -4.13 Million |
| Acquisitions | - | - | - | - | - | 11 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 212 Thousand | -272 Thousand | -150 Thousand | -1.79 Million | -4.26 Million | -4 Million |
| Financing Cash Flow | 13.76 Million | 17.25 Million | 29.71 Million | 8.98 Million | 10.84 Million | 14.84 Million |
| Debt repayment | -4.61 Million | -4.79 Million | -2.65 Million | -3.57 Million | -4.84 Million | -158 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 18.37 Million | 12.55 Million | 32.36 Million | 11.55 Million | 6 Million | 15 Million |
| Other Financing Activities | 13.76 Million | 9.5 Million | -2.65 Million | 1 Million | 9.68 Million | -158 Thousand |
| Accounts receivables | 645 Thousand | -374 Thousand | -1.07 Million | 502 Thousand | -331 Thousand | -281 Thousand |
| Accounts payables | 743 Thousand | 1.11 Million | -2.2 Million | 1.57 Million | -222 Thousand | -86 Thousand |
| Inventory | -938 Thousand | -844 Thousand | -959 Thousand | -529 Thousand | -158 Thousand | -567 Thousand |
| Other working capital | 743 Thousand | 1.11 Million | -2.2 Million | 1.57 Million | -222 Thousand | -367 Thousand |
| Cash at beginning of period | 5.85 Million | 8.68 Million | 1.48 Million | 2.86 Million | 7.56 Million | 4.63 Million |
| Cash at end of period | 923 Thousand | 5.85 Million | 8.68 Million | 1.48 Million | 2.86 Million | 6.76 Million |
| Capital Expenditure | -680 Thousand | -331 Thousand | -3.18 Million | -1.82 Million | -4.31 Million | -4.13 Million |
| Effect of forex changes on cash | - | 146 Thousand | - | -35 Thousand | - | - |
| Net cash flow / Change in cash | -4.92 Million | -2.83 Million | 7.19 Million | -1.37 Million | -4.7 Million | 2.12 Million |
| Free Cash Flow | -18.9 Million | -19.96 Million | -22.36 Million | -10.32 Million | -15.54 Million | -8.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.1 Million | -3.2 Million | -21.09 Million | -5.14 Million | -4.52 Million | -6.38 Million |
| Depreciation & Amortization | 500 Thousand | 502 Thousand | 2.68 Million | 506 Thousand | 707 Thousand | 733 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 450 Thousand | 450 Thousand | - | - |
| Other non-cash items | 4.05 Million | -1.14 Million | 5.54 Million | 2.25 Million | -830 Thousand | 173 Thousand |
| Investing Cash Flow | -14 Thousand | -31 Thousand | -467 Thousand | 3000.00 | -584 Thousand | 167 Thousand |
| Investments in PPE | - | - | -680 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -14 Thousand | -31 Thousand | 212 Thousand | 3000.00 | -584 Thousand | 167 Thousand |
| Financing Cash Flow | 771 Thousand | 5.61 Million | 13.76 Million | 3.15 Million | 2.28 Million | 5.38 Million |
| Debt repayment | - | - | -4.61 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 18.37 Million | - | - | - |
| Other Financing Activities | 771 Thousand | 5.61 Million | 13.76 Million | 3.15 Million | 2.28 Million | 5.38 Million |
| Accounts receivables | - | - | 645 Thousand | 645 Thousand | - | - |
| Accounts payables | - | - | 743 Thousand | - | - | - |
| Inventory | - | - | -938 Thousand | -938 Thousand | - | - |
| Other working capital | - | - | 743 Thousand | 743 Thousand | - | - |
| Cash at beginning of period | 1.65 Million | 923 Thousand | 5.85 Million | 1.16 Million | 4.11 Million | 4.04 Million |
| Cash at end of period | 1.85 Million | 1.65 Million | 923 Thousand | 923 Thousand | 1.16 Million | 4.11 Million |
| Capital Expenditure | - | - | -680 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 204 Thousand | 732 Thousand | -4.92 Million | -237 Thousand | -2.95 Million | 72 Thousand |
| Free Cash Flow | -553 Thousand | -4.85 Million | -18.9 Million | -3.39 Million | -4.64 Million | -5.47 Million |
RAT
WYLDF
BGEM
IGEX
BUFT
FUST